| Company Name: |
T&W GROUP |
| Tel: |
021-61551611 13296011611 |
| Email: |
contact@trustwe.com |
| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
inquiry@bocsci.com |
5-Aminocarbonylmethyl-2-thiouridine manufacturers
|
| | 5-Aminocarbonylmethyl-2-thiouridine Basic information |
| Product Name: | 5-Aminocarbonylmethyl-2-thiouridine | | Synonyms: | 5-Aminocarbonylmethyl-2-thiouridine;5-(2-Amino-2-oxoethyl)-2-thiouridine;Uridine, 5-(2-amino-2-oxoethyl)-2-thio- (9CI);5-Aminocarbonylmethyl-2-thiouridine,RNA-modified nucleoside ncm5s2U;5-Carbamoylmethyl-2-thiouridine, RNA modified nucleoside ncm5s2U | | CAS: | 29900-40-1 | | MF: | C11H15N3O6S | | MW: | 317.32 | | EINECS: | | | Product Categories: | | | Mol File: | 29900-40-1.mol |  |
| | 5-Aminocarbonylmethyl-2-thiouridine Chemical Properties |
| density | 1.72±0.1 g/cm3(Predicted) | | pka | 6.81±0.23(Predicted) |
| | 5-Aminocarbonylmethyl-2-thiouridine Usage And Synthesis |
| Uses | 5-Aminocarbonylmethyl-2-thiouridine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 5-Aminocarbonylmethyl-2-thiouridine Preparation Products And Raw materials |
|